| Literature DB >> 30658704 |
Mohamad Elaibaid1, Lama H Nazer2, Lama Shaikha3, Nada Al-Qadheeb4, Ruth Kleinpell5, Keith M Olsen6, Feras Hawari7.
Abstract
OBJECTIVES: Evaluation of published research in a region provides insight into relevant aspects of clinical care and research priorities. This study aimed to provide a comprehensive assessment of the type of critical care research published in the World Health Organization Eastern Mediterranean region (EMR) over a 10-year period.Entities:
Keywords: Critical care; Developing countries; Eastern Mediterranean; Research; Research output; Research productivity
Mesh:
Year: 2019 PMID: 30658704 PMCID: PMC6339311 DOI: 10.1186/s13104-019-4093-7
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Quality of critical care publications from the Eastern Mediterranean Region reflected by the sample size, study design, research fields, and journal assessment
| Country | No. | Sample size | Study design | Most common research fieldsa | Journal Assessment | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCT | NRCT | Observational | Meta-analysis | Review | Research field | Research field | Research field | IF Mean (SD) | Journals with IF>3 | H Index | |||
| Afghanistan | 1 | 410 | 0 | 0 | 1 (100%) | 0 | 0 | ID | N/A | N/A | 0.37 | 0 | 6 |
| Bahrain | 11 | 100 (4–1579) | 0 | 0 | 9 (81.8%) | 0 | 2 (18.2%) | ID | Q/S | Resp | 1.31 (1.7) | 1 | 3 |
| Djibouti | 2 | 131 (18–244) | 0 | 0 | 2 (100%) | 0 | 0 | Epidem | Heme | N/A | 0 | 0 | 0 |
| Egypt | 165 | 75 (15–7393) | 19 (11.5%) | 0 | 140 (84.8%) | 0 | 6 (3.6%) | ID | Resp | Renal | 1.34 (1.3) | 16 | 28 |
| Iran | 620 | 84 (4–18,682) | 129 (20.8%) | 27 (4.4%) | 439 (70.8%) | 3 (0.48%) | 22 (3.5%) | ID | Resp | Cardio | 0.54 (1.9) | 13 | 33 |
| Iraq | 8 | 222 (28–986) | 0 | 0 | 6 (75%) | 0 | 2 (25%) | ID | Q/S | Burns | 1.32 (0.7) | 0 | 10 |
| Jordan | 63 | 135 (6–10,792) | 1 (1.6%) | 1 (1.6%) | 58 (92.1%) | 0 | 3 (4.8%) | ID | Epid | Resp | 1.61 (1.6) | 6 | 11 |
| Kuwait | 26 | 94 (5–10,419) | 0 | 0 | 24 (92.3%) | 0 | 2 (7.7%) | ID | Epid | Q/S | 1.63 (1.0) | 2 | 17 |
| Lebanon | 42 | 66 (10–1506) | 0 | 3 (7.1%) | 32 (76.2%) | 0 | 7 (16.7%) | ID | Resp | Burn | 2.00 (2.0) | 5 | 21 |
| Libya | 5 | 423 (260–995) | 0 | 0 | 5 (100%) | 0 | 0 | ID | Q/S | Cardio | 0.40 (0.4) | 0 | 1 |
| Morocco | 39 | 145 (9–146) | 2 (5.1%) | 1 (2.6%) | 36 (92.3%) | 0 | 0 | ID | Resp | Q/S | 1.9 (2.9) | 5 | 11 |
| Oman | 16 | 65 (29–95) | 0 | 0 | 15 (93.8%) | 0 | 1 (6.3%) | ID | Resp | Epid | 0.58 (1.1) | 0 | 10 |
| Pakistan | 95 | 144 (3–5800) | 2 (2.1%) | 0 | 89 (93.7%) | 0 | 4 (4.2%) | ID | Epid | CV | 1.0 (1.2) | 5 | 17 |
| Palestine | 5 | 123 (13–275) | 0 | 0 | 5 (100%) | 0 | 0 | P/F | ID | CPR | 1.13 (1.6) | 1 | 2 |
| Qatar | 36 | 201 (36–1036) | 1 (2.8%) | 0 | 33 (91.7%) | 0 | 2 (5.6%) | ID | Epid | Org Don | 1.35 (1.1) | 1 | 11 |
| Saudi Arabia | 273 | 130 (6–256,195) | 11 (4%) | 2 (0.73%) | 214 (78.4%) | 0 | 46 (16.9%) | ID | Q/S | Resp | 1.7 (2.3) | 36 | 40 |
| Sudan | 6 | 99 (85–139) | 0 | 0 | 6 (100%) | 0 | 0 | Epidem | Resp | Renal | 0.36 (1.6) | 0 | 2 |
| Somalia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | N/A | N/A | 0 | 0 | 0 |
| Syria | 3 | 80b | 0 | 0 | 2 (66.7%) | 0 | 1 (33.3%) | ID | Q/S | Admin | 0 | 0 | 2 |
| Tunisia | 102 | 101 (6–5872) | 6 (5.9%) | 1 (0.98%) | 90 (88.2%) | 3 (2.9%) | 2 (1.96%) | ID | Resp | Heme | 1.9 (2.9) | 19 | 28 |
| United Arab Emirates | 16 | 117 (18–386) | 1 (6.25%) | 0 | 12 (75%) | 0 | 3 (18.8%) | ID | Q/S | Trauma | 1.46 (1.2) | 1 | 13 |
| Yemen | 3 | 129 (25–387) | 0 | 0 | 3 (100%) | 0 | 0 | Q/S | Education | Cardio | 0.47 (0.4) | 0 | 1 |
IF impact factor, H-index number of h articles that received h citations
a The major research field of articles was classified as: administration (Admin), burn, cardiovascular (CVD), cardio-pulmonary resuscitation (CPR), education, endocrine/nutrition, epidemiology (Epid), ethics/end of life/palliative, gastrointestinal, hematology (Heme), immunology/transplant, infectious diseases (ID), neuroscience, organ donation (Org Don) patient and family support (P/F), pharmacology, professional development, quality and safety (Q/S), renal, respiratory (Resp), surgery, and trauma
bSample size available for only one of the two observational studies
Fig. 1Flow chart of the search strategy to identify published critical care research from the Eastern Mediterranean Region
Number of published critical care research from the Eastern Mediterranean Region and the type of patient populations studied
| Country | Number of publications | Patient population | |||||
|---|---|---|---|---|---|---|---|
| Total number | Adjusted for populationa | Adjusted for GDPb | Adults | Children | Neonates | Pregnant | |
| Afghanistan | 1 | 0.028 | 0.05 | 1 (100%) | 0 | 0 | 0 |
| Bahrain | 11 | 7.33 | 0.31 | 7 (63.6%) | 0 | 3 (27.3%) | 1 (9.1%) |
| Djibouti | 2 | 2.0 | 1.1 | 2 (100%) | 0 | 0 | 0 |
| Egypt | 165 | 1.70 | 0.7 | 82 (49.7%) | 21 (12.7%) | 59 (35.8%) | 3 (1.8%) |
| Iran | 620 | 7.64 | 1.4 | 487 (78.5%) | 21 (3.4%) | 111 (17.9%) | 1 (0.16%) |
| Iraq | 8 | 0.20 | 0.04 | 4 (50%) | 0 | 2 (25%) | 2 (25%) |
| Jordan | 63 | 6.50 | 1.6 | 47 (74.6%) | 7 (11.1%) | 8 (12.7%) | 1 (1.6%) |
| Kuwait | 26 | 6.3 | 0.2 | 16 (61.5%) | 3 (11.5%) | 7 (26.9%) | 0 |
| Lebanon | 42 | 6.88 | 0.81 | 38 (90.5%) | 1 (2.4%) | 2 (4.8%) | 1 (2.4%) |
| Libya | 5 | 0.78 | 0.1 | 3 (60%) | 1 (20%) | 1 (20%) | 0 |
| Morocco | 39 | 1.09 | 0.36 | 26 (66.7%) | 6 (15.4%) | 2 (5.1%) | 5 (12.8%) |
| Oman | 16 | 3.48 | 0.22 | 9 (56.3%) | 2 (12.5%) | 4 (25%) | 1 (6.25%) |
| Pakistan | 95 | 0.48 | 0.3 | 52 (54.7%) | 27 (28.4%) | 14 (14.7%) | 2 (2.1%) |
| Palestinec | 5 | 1.06 | 0.34 | 3 (60%) | 0 | 2 (40%) | 0 |
| Qatar | 36 | 13.8 | 0.21 | 32 (88.9%) | 2 (5.6%) | 2 (5.6%) | 0 |
| Saudi Arabia | 273 | 8.30 | 0.40 | 218 (79.8%) | 24 (8.8%) | 30 (11%) | 1 (0.4%) |
| Sudan | 6 | 0.15 | 0.05 | 0 | 0 | 5 (83.3%) | 1 (16.7%) |
| Somalia | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Syria | 3 | 0.16 | 0.07 | 3 (100%) | 0 | 0 | 0 |
| Tunisia | 102 | 8.87 | 2.5 | 75 (73.5%) | 13 (12.7%) | 11 (10.8%) | 3 (2.9%) |
| United Arab Emirates | 16 | 1.7 | 0.04 | 11 (68.8%) | 1 (6.25%) | 4 (25%) | 0 |
| Yemen | 3 | 0.11 | 0.16 | 3 (100%) | 0 | 0 | 0 |
aData reflect the most recent statistics reported by the World Bank, which was from 2017 for all countries as follows in million: Afghanistan 35.5, Bahrain 1.5, Djibouti 0.96, Egypt 97.5, Iran 81.2, Iraq 38.3, Jordan 9.7, Kuwait 4.1, Lebanon 6.1, Libya 6.4, Morocco 35.7, Oman 4.6, Pakistan 197, Palestine 4.7, Qatar 2.6, Saudi Arabia 32.9, Sudan 40.5, Somalia 14.7, Syria 18.3, Tunisia 11.5, United Arab Emirates 9.4, and Yemen 28.3
b Data reflect the most recent statistics reported by the World Bank, which was 2017 for all countries except Yemen (2016) and Syria (2007), as follows in billion US dollar: Afghanistan 20.8, Bahrain 35.3, Djibouti 1.8, Egypt 235.3, Iran 439.5, Iraq 197.7, Jordan 40, Kuwait 120, Lebanon 51.8, Libya 51, Morocco 109.1, Oman 72.6, Pakistan 305, Palestine 14.5, Qatar 167.6, Saudi Arabia 683.8, Sudan 117.5, Somalia 7.4, Syria 40.4, Tunisia 40.2, United Arab Emirates 382.6, Yemen 18.2
c Listed as West Bank and Gaza by the World Bank